Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 14,733 | 15,219 | 12,596 | 13,035 | 11,672 |
| Operating Income | -14,733 | -15,219 | -12,596 | -13,035 | -11,672 |
| Interest Expense | 3 | 4 | 3 | 2 | 0 |
| Other Income | 17,119 | 646 | 739 | 774 | 594 |
| Pre-tax Income | 2,383 | -14,577 | -11,860 | -12,263 | -11,078 |
| Net Income Continuous | 2,383 | -14,577 | -11,860 | -12,263 | -11,078 |
| Net Income | $2,383 | $-14,577 | $-11,860 | $-12,263 | $-11,078 |
| EPS Basic Total Ops | 13.81 | -32.67 | -26.68 | -28.28 | -123.80 |
| EPS Basic Continuous Ops | 13.84 | -32.68 | -26.71 | -28.26 | -123.74 |
| EPS Diluted Total Ops | 13.81 | -32.67 | -26.68 | -28.28 | -123.80 |
| EPS Diluted Continuous Ops | 79.85 | -32.68 | -26.71 | -28.26 | -123.74 |
| EBITDA(a) | $-14,010 | $-14,391 | $-11,773 | $-12,217 | $-10,336 |